Safety of Anal Curcumin — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety of Anal Curcumin — Stella

Recruiting

Back to Anal High Grade Squamous Intraepithelial Lesion trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Grady Memorial Hospital, Atlanta, Georgia

Grady Hospital - Ponce De Leon Clinic, Atlanta, Georgia

Key details

Phase

Early testing

Sponsor

Lisa Flowers

Enrollment target

~48 participants

Started

March 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

30 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov